When does UG Healthcare report earnings and why does it matter for 8K7.SI stock?

UG Healthcare reports on 11 Feb 2026. The results will reveal demand trends, gross margins, and inventory guidance. These factors can move 8K7.SI stock sharply in pre-market trading because the company’s valuation is sensitive to margin and order-book updates.

What is Meyka AI’s price forecast for 8K7.SI stock?

Meyka AI's forecast model projects a yearly target of S$0.10 for 8K7.SI stock, implying about 12.63% upside from S$0.093. Forecasts are model-based projections and not guarantees.

What are the main risks to consider for 8K7.SI stock after earnings?

Key risks are falling glove prices, rising raw material costs, slow receivables, and long inventory (215.09 days). Weak cash flow and negative EPS increase downside risk if revenue or margin guidance disappoints.

How does UG Healthcare compare to healthcare peers for investors watching 8K7.SI stock?

UG Healthcare trades at lower valuation (PB ~0.37) than many healthcare peers. However, peers show stronger margins and higher P/E averages (sector PE ~22.18), reflecting better profitability and scale.

SG Stocks

UG Healthcare (8K7.SI, SES) pre-market: earnings due 11 Feb 2026 could shift price

ByHuzaifa Zahoor February 7, 2026

We open pre-market on 07 Feb 2026 with 8K7.SI stock at S$0.093, and UG Healthcare’s upcoming earnings on 11 Feb 2026 is the immediate catalyst. Volume has been active at 643,500 shares today, above the 30-day average. Investors should watch margin drivers and inventory turns; recent metrics show negative EPS and thin margins that could steer short-term moves. This earnings report may change the market’s view on valuation and supply-demand for Unigloves products in Singapore and global markets.